Mehrdad Mozaffarian is an Associate Professor at the Department of Chemical Engineering, Amirkabir University of Technology. Dr. Mozaffarian obtained a B.Sc. in Petrochemical Engineering at Amirkabir University of Technology in 1984, an M.Sc. in Advanced Chemical Engineering at Amirkabir University of Technology in 1988 and a Ph.D. in Chemical & Petroleum Engineering at the University of Calgary in 2012. The skills and expertise include Adsorption, Enhanced Oil Recovery, Surface Adsorption, Porous Materials, and Mesoporous Materials.
Jose Luis Pedraz obtained his Degree and doctorate in pharmacy from the University of Salamanca. He was a Professor at the University of Salamanca, until 1992, and has been a professor at the University of the Basque Country since 1992. Postdoctoral stay in the Department of Neonatal Pharmacology at the Mario Negri Institute in Milan in 1986. He completed my training in the R&D departments of multinational pharmaceutical companies such as UPJOHN and Merrell Down Research Institute in 1989. He is a principal researcher in the NanoBioCel group of the UPV/EHU, which is a Consolidated Group of Excellence type A of the Basque Government. Within CIBER BBN, he is the head and director of the medicine formulation laboratory that belongs to the singular scientific infrastructure (ICTS) Nanbiosis. Founder and director of the Pharmaceutical Development Unit of the Basque Country currently TECNALIA Pharma Labs integrated into the Tecnalia Corporation within a joint project with the UPV/EHU of which he is a scientific director. His research work focuses on the area of Drug Delivery, specifically on the design and development of particular microsystems, non-viral vectors for gene therapy, microencapsulation of cells for the development of bioartificial organs and scaffolds and 3d bioprinting techniques with applications in cell therapy and generative medicine.
Gustavo Puras obtained his PhD degree from the Pharmacology Department at the University of the Basque Country (Spain, June 2002). He worked for the Lloyds Pharmacy company in the United Kingdom of Great Britain as a European Pharmacist until June 2005. In September 2005, Dr Puras was hired as a Researcher-Assistant member at the University of Texas-Brownsville (UTB, EEUU). In this period, he was a faculty member of the Universidad Autónoma de Tamaulipas (México). In September 2009, Dr Puras was hired as a researcher for the CIBER-BBN in the group directed by Dr José Luis Pedraz. Since March 2012, Dr Puras has worked as a faculty member in the Laboratory of Pharmacy and Pharmaceutical Technology of the University of the Basque Country. His research interest is focused mainly on ocular pharmacology, nanotechnology and drug delivery systems, especially on the synthesis, design and characterization of non-viral vectors for gene delivery systems with applications to retinal inherited diseases, cystic fibrosis and CNS diseases.
Jon Zarate Graduated in 2002 and obtained a doctor degree (2007) in pharmacy from the UPV/EHU. Since 2011 he has been an associate professor of the Department of Pharmacy and Food Sciences of the Faculty of Pharmacy of the UPV / EHU. Professor of the doctoral program in Drug Research and Evaluation. Application of Pharmaceutical Technology to the Development of Advanced Therapies and the master's degree in Pharmacology. Development, Evaluation and Rational Use of Medicines. Director of the postgraduate degree "Language Management in Healthcare" since the 2019/20 academic year (EHU, UEU, with the support of UEMA). Accredited in the program for the evaluation of teaching activity DOCENTIAZ. Director of the scientific journal in Basque Ekaia of the UPV/EHU (2010-2014). Vice-Rector of Basque, Multilingualism and Continuing Training of the UPV/EHU (2014-2021). Researcher in the NanoBioCel research group of the UPV/EHU, a consolidated type A group of the Basque University System. Co-author of a significant number of scientific articles: 28 articles in journals indexed in JCR. 2 books, 4 book chapters and 12 articles in magazines published in Basque. Participant in about 30 national and international research projects and more than twenty research conferences.
Ilia Villate graduated in Human Biology (2013) and obtained a master's degree in Pharmaceutical Industry and Biotechnology (2014) at the University Pompeu Fabra. She developed her Ph.D. in non-viral gene delivery at the NanoBioCel research group of the Faculty of Pharmacy at the University of the Basque Country (UPV/EHU), with an international 5-month research stay at the Chemical and Biomolecular Engineering department of the University of California, Los Angeles (UCLA). She obtained her international Doctorate in 2018 and since 2020, she is a postdoctoral researcher in the NanoBioCel group. She has combined her research with university teaching in the Faculties of Pharmacy and Medicine of the UPV/EHU, where she has taught the subjects of Pharmaceutical Technology, Galenic Pharmacy, Applied Medical Pharmacology, Research Project, Extension of Organic Chemistry, Chemistry II, Toxicology and Dermopharmacy. She is part of the NanoBioCel research group and of the CiberBBN. Her main research lines focus on the field of non-viral vectors for gene therapy. Specifically, her research work is based on the development and evaluation of non-viral vectors based on polymers, lipids or other nanomaterials, able to transport different therapeutic nucleic acids into target cells.
Naghmeh Hadidi is an Experienced Associate Professor with a demonstrated history of working in the pharmaceuticals industry. She is skilled in Pharmaceutics, Generic Programming, Good Laboratory Practice (GLP), Medical Devices, and Vaccines. She is a Strong operation professional with a Doctor of Philosophy (PhD) focused in Pharmaceutics from Shaheed Beheshti University of Medical Sciences.
